Wedge Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.9M Sell
234,921
-168,903
-42% -$16.3M 0.45% 83
2026
Q2
$31.6M Buy
+403,824
New +$27.5M 0.52% 77

Other funds holding HALO

Wedge Capital Management's HALO Position: Q3 2026 in Review

Wedge Capital Management reduced its Halozyme (HALO) stake by 42% in Q3 2026, selling an estimated $16.3M and leaving 234,921 shares worth $25.9M. The position accounts for 0.45% of the portfolio, ranked #83.

Wedge Capital Management first reported a position in HALO in Q2 2026 and has held it in 2 quarters since. The position peaked at $31.6M in Q2 2026. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Wedge Capital Management held 234,921 shares of Halozyme worth $25.9M as of Q3 2026.
  • Wedge Capital Management sold 168,903 Halozyme shares in Q3 2026, an estimated $16.3M.
  • Halozyme made up 0.45% of Wedge Capital Management's portfolio in Q3 2026, its #83 holding.
  • Wedge Capital Management first reported a position in Halozyme in Q2 2026 and has held it in 2 quarters since.
  • Wedge Capital Management's Halozyme position peaked at $31.6M in Q2 2026.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Wedge Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.